Jadwiga Zalewska-Kaszubska

Summary

Affiliation: University of Lodz
Country: Poland

Publications

  1. ncbi Effect of repeated treatment with topiramate on voluntary alcohol intake and beta-endorphin plasma level in Warsaw alcohol high-preferring rats
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Lodz, Muszynskiego 1, 90 151 Lodz, Poland
    Psychopharmacology (Berl) 225:275-81. 2013
  2. ncbi Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with levetiracetam: a preliminary study
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Lodz, Muszynskiego 1, PL 90 151 Lodz, Poland
    Physiol Behav 102:538-41. 2011
  3. ncbi Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Łódź, Muszynskiego 1, PL 90 151 Łódź, Poland
    Neurosci Lett 388:45-8. 2005
  4. ncbi Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Łódź, Muszynskiego 1, PL 90 151 Łódź, Poland
    Neurosci Lett 431:221-5. 2008
  5. ncbi Effect of acute administration of ethanol on beta-endorphin plasma level in ethanol preferring and non-preferring rats chronically treated with naltrexone
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Lodz, Muszynskiego 1, PL 90 151 Lodz, Poland
    Pharmacol Biochem Behav 85:155-9. 2006
  6. ncbi Effect of repeated treatment with topiramate on the beta-endorphin plasma level in rats selectively bred for high and low alcohol preference
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Lodz, Muszynskiego 1, PL 90 151 Lodz, Poland
    Prog Neuropsychopharmacol Biol Psychiatry 31:525-8. 2007
  7. ncbi Deficit in beta-endorphin peptide and tendency to alcohol abuse
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Lodz, Muszynskiego 1, PL 90 151 Lodz, Poland
    Peptides 26:701-5. 2005
  8. ncbi Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with naltrexone
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Lodz, Muszynskiego 1, PL 90 151 Lodz, Poland
    Physiol Behav 93:1005-10. 2008
  9. ncbi Binding of the new morphiceptin analogs to human MCF-7 breast cancer cells and their effect on growth
    Anna Janecka
    Department of Medicinal Chemistry, Medical University, Lodz, Mazowiecka 6 8, 92 215, Poland
    Regul Pept 120:237-41. 2004
  10. ncbi Characterization of histamine H(2)-like receptors in duck cerebral cortical membranes by [(3)H]tiotidine binding
    Jolanta B Zawilska
    Department of Pharmacodynamics, Medical University of Lodz, Poland
    Neurosci Lett 319:149-52. 2002

Detail Information

Publications11

  1. ncbi Effect of repeated treatment with topiramate on voluntary alcohol intake and beta-endorphin plasma level in Warsaw alcohol high-preferring rats
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Lodz, Muszynskiego 1, 90 151 Lodz, Poland
    Psychopharmacology (Berl) 225:275-81. 2013
    ..The rationale for topiramate as treatment for alcohol addiction is based on its multifaceted neurochemical activity that targets multiple neural pathways...
  2. ncbi Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with levetiracetam: a preliminary study
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Lodz, Muszynskiego 1, PL 90 151 Lodz, Poland
    Physiol Behav 102:538-41. 2011
    ....
  3. ncbi Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Łódź, Muszynskiego 1, PL 90 151 Łódź, Poland
    Neurosci Lett 388:45-8. 2005
    ..In WLP rats, repeated acamprosate treatment prevents the ethanol-induced increase in plasma beta-endorphin level. It may be concluded that acamprosate modulates the endogenous opioid system...
  4. ncbi Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Łódź, Muszynskiego 1, PL 90 151 Łódź, Poland
    Neurosci Lett 431:221-5. 2008
    ..We suppose that the anti-craving mechanism of acamprosate that has been reported to abolish excessive glutamate release during alcohol withdrawal may be accompanied by compensation for the beta-endorphin deficiency...
  5. ncbi Effect of acute administration of ethanol on beta-endorphin plasma level in ethanol preferring and non-preferring rats chronically treated with naltrexone
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Lodz, Muszynskiego 1, PL 90 151 Lodz, Poland
    Pharmacol Biochem Behav 85:155-9. 2006
    ..It is likely that effectiveness of naltrexone in reducing craving for alcohol results from the attenuation of the rewarding properties of ethanol and restoring the beta-endorphin deficit in reward system...
  6. ncbi Effect of repeated treatment with topiramate on the beta-endorphin plasma level in rats selectively bred for high and low alcohol preference
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Lodz, Muszynskiego 1, PL 90 151 Lodz, Poland
    Prog Neuropsychopharmacol Biol Psychiatry 31:525-8. 2007
    ..We propose that administration of topiramate may have different effects on the opioid system involved in dependence according to genetic susceptibilities to alcoholism...
  7. ncbi Deficit in beta-endorphin peptide and tendency to alcohol abuse
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Lodz, Muszynskiego 1, PL 90 151 Lodz, Poland
    Peptides 26:701-5. 2005
    ..Its release increases significantly after alcohol consumption. Clinical and laboratory studies confirm that certain genetically determined factors might increase the individual's vulnerability to alcohol abuse...
  8. ncbi Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with naltrexone
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University of Lodz, Muszynskiego 1, PL 90 151 Lodz, Poland
    Physiol Behav 93:1005-10. 2008
    ..This finding supports the proposition that the endogenous opioid system plays an important role in developing a craving for alcohol...
  9. ncbi Binding of the new morphiceptin analogs to human MCF-7 breast cancer cells and their effect on growth
    Anna Janecka
    Department of Medicinal Chemistry, Medical University, Lodz, Mazowiecka 6 8, 92 215, Poland
    Regul Pept 120:237-41. 2004
    ..However, none of the tested peptides significantly decreased cell proliferation of MCF-7 cells...
  10. ncbi Characterization of histamine H(2)-like receptors in duck cerebral cortical membranes by [(3)H]tiotidine binding
    Jolanta B Zawilska
    Department of Pharmacodynamics, Medical University of Lodz, Poland
    Neurosci Lett 319:149-52. 2002
    ....
  11. ncbi Use of low-energy laser as adjunct treatment of alcohol addiction
    Jadwiga Zalewska-Kaszubska
    Department of Pharmacodynamics, Medical University, Muszynskiego 1, 90 151 Lodz, Poland
    Lasers Med Sci 19:100-4. 2004
    ..Improvement in BDI-FS and increase in, beta-endorphin level were observed. These results suggest that laser therapy can be useful as an adjunct treatment for alcoholism...